Development of a method for protein quantification via isotope dilution ICP-MS for application on an Alzheimer’s biomarker

  • Inductively coupled plasma mass spectrometry (ICP-MS) is a powerful method for the matrix-independent quantitative analysis of target elements. Developed for the use in inorganic trace analysis, ICP-MS is nowadays emerging as a valuable tool for bioanalytical questions. Especially the use of ICP-MS for quantitative proteomics by measuring heteroatoms has gained popularity in the last decade, considering that established quantification methods like organic mass spectrometry depend on the existence of matched protein and peptide standards or labelling of the target protein. The need for reliable quantification of proteins is constantly growing, but only a limited number of well characterized and quantified protein standards are available so far. Not only in basic research, but also in a clinical context, accurately quantified, traceable protein standards are needed to ensure comparability of measurements between laboratories. One disease with a major impact on our ageing society isInductively coupled plasma mass spectrometry (ICP-MS) is a powerful method for the matrix-independent quantitative analysis of target elements. Developed for the use in inorganic trace analysis, ICP-MS is nowadays emerging as a valuable tool for bioanalytical questions. Especially the use of ICP-MS for quantitative proteomics by measuring heteroatoms has gained popularity in the last decade, considering that established quantification methods like organic mass spectrometry depend on the existence of matched protein and peptide standards or labelling of the target protein. The need for reliable quantification of proteins is constantly growing, but only a limited number of well characterized and quantified protein standards are available so far. Not only in basic research, but also in a clinical context, accurately quantified, traceable protein standards are needed to ensure comparability of measurements between laboratories. One disease with a major impact on our ageing society is Alzheimer’s disease (AD), which is still challenging to diagnose. As this is also due to a lack in comparability and accuracy of existing biomarker assays, the community would greatly benefit from well quantified protein biomarker standards. In this work, we applied isotope dilution analysis (IDA) using ICP-MS to quantify proteins of known stoichiometry via their sulfur content. Sulfur is present in two amino acids, cysteine and methionine, and hence exists in nearly all proteins. Simple strategies were employed for the detection of low molecular sulfur species to correct for sulfur contaminants and allow for reliable quantification of various proteins. We report the protein mass fractions with expanded uncertainties of a standard reference material and commercially available proteins determined by sulfur IDA. The herein developed method can be applied for the reliable and traceable quantification of pure proteins and will be used for the quantification of an AD biomarker. Our target is the tau protein, as brain load and distribution of tau is highly correlated with the clinical progression of AD.zeige mehrzeige weniger

Volltext Dateien herunterladen

  • 2019-06-26-ReMiND Konferenz_Nora Lemke.pdf
    eng

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar Anzahl der Zugriffe auf dieses Dokument
Metadaten
Autor*innen:Nora Lemke
Koautor*innen:Ahmed El-Khatib, F. Theuring, Norbert Jakubowski, Jochen Vogl
Dokumenttyp:Vortrag
Veröffentlichungsform:Präsentation
Sprache:Englisch
Jahr der Erstveröffentlichung:2019
Organisationseinheit der BAM:1 Analytische Chemie; Referenzmaterialien
1 Analytische Chemie; Referenzmaterialien / 1.1 Anorganische Spurenanalytik
DDC-Klassifikation:Naturwissenschaften und Mathematik / Chemie / Analytische Chemie
Freie Schlagwörter:ICP-MS; Isotope dilution; Proteins; Quantification
Themenfelder/Aktivitätsfelder der BAM:Chemie und Prozesstechnik
Chemie und Prozesstechnik / Chemische Charakterisierung und Spurenanalytik
Veranstaltung:ReMiND 2019 Biomolecules in Neurodegenerative Diseases
Veranstaltungsort:Braunschweig, Germany
Beginndatum der Veranstaltung:26.06.2019
Enddatum der Veranstaltung:27.06.2019
Verfügbarkeit des Dokuments:Datei im Netzwerk der BAM verfügbar ("Closed Access")
Datum der Freischaltung:15.07.2019
Referierte Publikation:Nein
Eingeladener Vortrag:Nein
Einverstanden
Diese Webseite verwendet technisch erforderliche Session-Cookies. Durch die weitere Nutzung der Webseite stimmen Sie diesem zu. Unsere Datenschutzerklärung finden Sie hier.